Drug Type Small molecule drug |
Synonyms Tripelennamine, Tripelennamine hydrochloride (USP), 曲吡那敏 + [4] |
Target |
Mechanism H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date CA (31 Dec 1947) |
Regulation- |
Molecular FormulaC16H21N3 |
InChIKeyUFLGIAIHIAPJJC-UHFFFAOYSA-N |
CAS Registry91-81-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02091 | Tripelennamine Hydrochloride |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Asthma | CN | 01 Jan 1995 | |
Dermatitis | CN | 01 Jan 1995 | |
Eczema | CN | 01 Jan 1995 | |
Hypersensitivity | CN | 01 Jan 1995 | |
Rhinitis, Allergic | CN | 01 Jan 1995 | |
Rhinitis, Allergic, Seasonal | CN | 01 Jan 1995 | |
Urticaria | CN | 01 Jan 1995 |